Diabeloop announced today that it leveraged its diabetes management software to integrate insulin pens into its hybrid closed-loop system. Paris-based Diabeloop’s DBL-4pen, a unique app, offers new opportunities for the personalized management of people with type 1 and type 2 diabetes. Get the full story at our sister site, Drug Delivery Business News.
Patient Monitoring
Masimo completes acquisition of Sound United
Masimo (Nasdaq:MASI) announced today that it completed its previously announced acquisition of Sound United. Irvine, California-based Masimo announced in February that it would spend $1.025 billion to acquire Viper Holdings, the parent company of Sound United. Wall Street’s response saw Masimo’s stock drop by 35%, with analysts unsure about the consumer tech acquisition, saying it […]
LivaNova launches patient monitor for cardiopulmonary bypass procedures
Livanova (Nasdaq:LIVN) announced today that it began the commercial launch of its Essenz patient monitor. London-based LivaNova launched the Essenz patient monitor in the U.S. and Europe, having recently received both FDA 510(k) clearance and CE mark approval. The monitor uses a patient-tailored approach to improve efficiency and quality of care during cardiopulmonary bypass (CPB) […]
DiabetesWise launches platform for provider decision-making on diabetes devices
DiabetesWise announced that it launched its DiabetesWise Pro website to help providers make informed decisions on diabetes devices. Stanford, California–based DiabetesWise says it designed the website as an easy-to-use and free tool for providers to access in the clinical practice or at the point of care. They can identify the best available diabetes device on […]
Senseonics announces first Eversense E3 CGM implant in U.S.
Senseonics (NYSE:SENS) announced today that the first patient was implanted with its next-generation Eversense E3 continuous glucose monitor. Germantown, Maryland-based Senseonics, in partnership with Ascensia Diabetes Care, launched the Eversense E3 long-term implantable CGM system in the U.S. earlier this week. The system received FDA approval in February for use lasting up to six months (180 days), making […]
Ascensia launches Senseonics’ next-gen 180-day Eversense E3 CGM in U.S.
Ascensia Diabetes Care announced today that it launched the Senseonics (NYSE:SENS) Eversense E3 system in the U.S. The next-generation Eversense E3 continuous glucose monitoring (CGM) system, developed by Germantown, Maryland-based Senseonics, received FDA approval in February for use lasting up to six months (180 days), making it the longest-lasting CGM sensor available in the U.S. Get the full story […]
Dexcom launches Dexcom One CGM in the UK
Dexcom (NSDQ:DXCM) announced today that it launched the new Dexcom One continuous glucose monitoring (CGM) system in the United Kingdom. San Diego–based Dexcom designed the Dexcom One system as an easy-to-use, real-time CGM (rt-CGM) that it aims to make more affordable and accessible for people with diabetes in the UK. Get the full story at our […]
BrainCheck appoints new chief financial, revenue officers
BrainCheck announced today that it appointed Trey Swain as its chief financial officer and Matthew Cerullo as chief revenue officer. Houston-based BrainCheck, which develops rapid, mobile cognitive assessment and decision support technology, said in a news release that the personnel announcement follows a $10 million Series B funding round completed in November 2021 as the […]
Analysts say high payor coverage, increased CGM adoption bodes well for Abbott, Dexcom
Analysts have suggested that companies like Abbott (NYSE:ABT) and Dexcom (Nasdaq:DXCM) may benefit from expected reimbursement progress. BTIG hosted a conference call with North Shore Medical Center (Salem, Massachusetts) Medical Director Dr. Gary Cohen and Healthcare Analytics, LLC analyst and consultant Dr. Joshua Cohen. The two experts offered insights into prescriber and patient interest in continuous glucose monitors (CGMs) […]
Terumo, Glooko partner for diabetes data sharing with insulin patch pump
Terumo (TSE:4543) and Glooko today announced a collaboration to integrate their technologies and create new diabetes data sharing solutions. In the new technology integration, users with diabetes will be able to transfer recorded data from the Terumo Medisafe With insulin patch pump into the Glooko management platform, allowing for the visualization of insulin dosage, food and activities in […]
Owens & Minor completes $1.6B acquisition of Apria
Owens & Minor (NYSE:OMI) announced today that it closed its previously announced $1.6 billion acquisition of Apria. The Richmond, Virginia-based company previously announced the planned acquisition of Apria, a developer of home medical equipment for respiratory therapy, sleep apnea treatment, negative pressure wound therapy, and continuous glucose monitoring, in January 2022. According to a news […]